World News: 21:05 GMT Tuesday 28th August 2018. [Emisphere Technologies, Inc. via Globe Newswire via SPi World News]
ROSELAND NJ Aug 28 2018 GLOBE NEWSWIRE -- On20 2018 Novo Nordisk AS Novo Nordisk the headline results from 5 a phase 3a trial with oral semaglutide in adults with type 2 diabetes and renal impairmen t. A co...
Globe Newswire: 21:05 GMT Tuesday 28th August 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.